Working… Menu
Trial record 1 of 1 for:    NCT02536469
Previous Study | Return to List | Next Study

HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02536469
Recruitment Status : Completed
First Posted : August 31, 2015
Last Update Posted : February 3, 2017
This trial was conducted previously by Cormorant
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2016
Actual Study Completion Date : November 2016